Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY24 results · Oct–Dec 2023
Metropolis Healthcare reported revenue from operations of ₹291.12 crore (up 2.0% from Q3 FY23) and net profit of ₹27.29 crore (down 23.9% from Q3 FY23) for Q3 FY24 (Oct–Dec 2023), on a consolidated basis.
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 291.12 | 285.46 | +2.0% | 308.50 | −5.6% |
| Other income | 2.31 | 6.62 | −65.2% | 1.22 | +89.2% |
| Total income | 293.42 | 292.08 | +0.5% | 309.72 | −5.3% |
| Profit before tax | 36.85 | 47.97 | −23.2% | 48.11 | −23.4% |
| Net profit for the period | 27.29 | 35.86 | −23.9% | 35.66 | −23.5% |
| Attributable to shareholders of the company | 27.16 | 35.80 | −24.1% | 35.45 | −23.4% |
| EPS, basic (₹) | 5.30 | 6.99 | −24.2% | 6.92 | −23.4% |
| Net margin (%) | 9.4 | 12.6 | 11.6 |
| Item | Q3 FY24 | Q3 FY23 | YoY | Q2 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 269.41 | 264.55 | +1.8% | 285.46 | −5.6% |
| Other income | 5.19 | 6.79 | −23.6% | 2.01 | +158.4% |
| Total income | 274.60 | 271.35 | +1.2% | 287.46 | −4.5% |
| Profit before tax | 34.63 | 44.38 | −22.0% | 42.49 | −18.5% |
| Net profit for the period | 26.70 | 32.83 | −18.7% | 31.28 | −14.6% |
| EPS, basic (₹) | 5.21 | 6.41 | −18.7% | 6.11 | −14.7% |
| Net margin (%) | 9.9 | 12.4 | 11.0 |
Consolidated
- Filed with BSE
- 05 Feb 2024, 11:26 IST
- Board meeting
- 02 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 05 Feb 2024, 11:26 IST
- Board meeting
- 02 Feb 2024
- Period
- 01 Oct 2023 to 31 Dec 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE